Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Table 11 Estimate of treatment effect of all hemorrhagic complication stratified for hip vs knee adjusted for effects of age, gender, and NSAID and hetastarch used

From: Low dose compared to variable dose Warfarin and to Fondaparinux as prophylaxis for thromboembolism after elective hip or knee replacement surgery; a randomized, prospective study

  Adjusted odds ratio(95 % CI) p-value
Hip Fondaparinux vs. variable dose warfarin 0.45 (0.14-1.44) 0.238
  Fixed dose warfarin vs. variable dose warfarin 0.40 (0.12-1.32) 0.170
  Fixed dose warfarin vs. fondaparinux 0.89 (0.24-3.3645) 0.978
Knee Fondaparinux vs. variable dose warfarin 3.45 (1.15-10.32) 0.022
  Fixed dose warfarin vs. variable dose warfarin 1.78 (0.56-5.68) 0.471
  Fixed dose warfarin vs. fondaparinux 0.52 (0.20-1.36) 0.248